FSK Stock Analysis: FS KKR Capital | NYSE
Asset Management | NYSE, USA | Market Cap: 2.996m USD | 12M Return: -17% | US3026352068 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 21.1M
EPS Trend: -94.3%
Qual. Beats: 0
Rev. Trend: -81.4%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
FS KKR Capital Corp. (NYSE: FSK) is a Business Development Company (BDC) that invests primarily in debt securities of private U.S. middle-market companies, focusing on senior secured loans (first and second lien) and, to a lesser extent, subordinated or mezzanine debt. The firm also opportunistically invests in corporate bonds and may take minority equity positions alongside its debt investments, often receiving warrants as additional consideration.
FSK targets established small and middle-market U.S. companies, avoiding start-ups, turnarounds, and speculative business plans. The description notes a preference for upper middle-market borrowers with EBITDA typically ranging from $50 million to over $150 million at the time of investment. Loan acquisitions are made through both secondary market transactions and direct primary market purchases from issuers.
As a BDC, FSK operates under the Investment Company Act of 1940, a regulatory framework that generally requires such companies to distribute the majority of their taxable income to shareholders, which typically results in above-average dividend yields. Exits are pursued through privately negotiated OTC sales, loan repayments, IPOs, mergers, or recapitalizations.
- Net interest income expands on elevated base rates
- Middle market credit quality deteriorates as defaults rise
- New investment spreads compress amid competition for deals
| Net Income: -375.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 7.64 > 1.0 |
| NWC/Revenue: 35.55% < 20% (prev 71.41%; Δ -35.86% < -1%) |
| CFO/TA 0.11 > 3% & CFO 1.33b > Net Income -375.0m |
| Current Ratio: 2.41 > 1.5 & < 3 |
| Outstanding Shares: last quarter (280.2m) vs 12m ago 0.06% < -2% |
| Gross Margin: 60.55% > 18% (prev 39.69%; Δ 20.86% > 0.5%) |
| Asset Turnover: 7.13% > 50% (prev 5.25%; Δ 1.88% > 0%) |
| Interest Coverage Ratio: -0.01 > 6 (EBIT TTM -3.00m / Interest Expense TTM 437.0m) |
| A: 0.03 (Total Current Assets 576.0m - Total Current Liabilities 239.0m) / Total Assets 12.0b |
| B: -0.34 (Retained Earnings -4.08b / Total Assets 12.0b) |
| C: -0.00 (EBIT TTM -3.00m / Avg Total Assets 13.3b) |
| D: 0.78 (Book Value of Equity 5.27b / Total Liabilities 6.73b) |
| Altman-Z'' = -0.10 = B |
As of October 17, 2026, the stock is trading at USD 10.33 with a total of 2,255,956 shares traded. Over the past week, the price has changed by -4.70%, over one month by -10.41%, over three months by -3.48% and over the past year by -17.02%.
Current recommended Stop Loss: 9.60 (which is 7.1% or 2.6 ATR below the current price).
FS KKR Capital has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold FSK.
- StrongBuy: 1
- Buy: 0
- Hold: 9
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 12.1 | 16.7% |
P/E Forward = 7.9239
P/S = 2.278
P/B = 0.6031
P/EG = 3.2724
Revenue TTM = 948.0m USD
EBIT TTM = -3.00m USD
EBITDA TTM = 21.0m USD
Long Term Debt = 7.63b USD (from longTermDebt, last fiscal year)
Short Term Debt = unknown (none)
Debt = 7.63b USD (corrected: LT Debt 7.63b + ST Debt none)
Net Debt = 7.53b USD (calculated: Debt 7.63b - CCE 107.0m)
Enterprise Value = 10.5b USD (3.00b + Debt 7.63b - CCE 107.0m)
Interest Coverage Ratio = -0.01 (Ebit TTM -3.00m / Interest Expense TTM 437.0m)
EV/FCF = 7.93x (Enterprise Value 10.5b / FCF TTM 1.33b)
FCF Yield = 12.61% (FCF TTM 1.33b / Enterprise Value 10.5b)
FCF Margin = 140.0% (FCF TTM 1.33b / Revenue TTM 948.0m)
Net Margin = -39.56% (Net Income TTM -375.0m / Revenue TTM 948.0m)
Gross Margin = 60.55% ((Revenue TTM 948.0m - Cost of Revenue TTM 374.0m) / Revenue TTM)
Gross Margin QoQ = 65.17% (prev 27.62%)
Tobins Q-Ratio = 0.88 (Enterprise Value 10.5b / Total Assets 12.0b)
Interest Expense / Debt = 5.72% (Interest Expense 437.0m / Debt 7.63b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -2.37m (EBIT -3.00m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.41 (Total Current Assets 576.0m / Total Current Liabilities 239.0m)
Debt / Equity = 1.45 (Debt 7.63b / totalStockholderEquity, last quarter 5.27b)
Debt / EBITDA = 358.4 (Net Debt 7.53b / EBITDA 21.0m)
Debt / FCF = 5.67 (Net Debt 7.53b / FCF TTM 1.33b)
Total Stockholder Equity = 5.64b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.82% (Net Income -375.0m / Total Assets 12.0b)
RoE = -6.65% (Net Income TTM -375.0m / Total Stockholder Equity 5.64b)
RoCE = -0.02% (EBIT -3.00m / Capital Employed (Equity 5.64b + L.T.Debt 7.63b))
RoIC = -0.02% (negative operating profit) (NOPAT -2.37m / Invested Capital 11.7b)
WACC = 5.63% (E(3.00b)/V(10.6b) * Re(8.45%) + D(7.63b)/V(10.6b) * Rd(5.72%) * (1-Tc(0.21)))
Discount Rate = 8.45% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 52.50 | Cagr: 0.03%
[DCF] Terminal Value 77.97% ; FCFF base≈995.8m ; Y1≈1.14b ; Y5≈1.68b
[DCF] Fair Price = 64.25 (EV 25.3b - Net Debt 7.53b = Equity 17.8b / Shares 276.3m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -94.34 | EPS CAGR: -17.06% | SUE: 0.34 | # QB: 0
Revenue Correlation: -81.42 | Revenue CAGR: -19.00% | SUE: 0.01 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.41 | Chg30d=-3.40% | Revisions=-18% | Analysts=11
EPS current Year (2026-12-31): EPS=1.62 | Chg30d=+0.16% | Revisions=+30% | GrowthEPS=-30.6% | GrowthRev=-25.0%
EPS next Year (2027-12-31): EPS=1.50 | Chg30d=-0.72% | Revisions=-8% | GrowthEPS=-7.5% | GrowthRev=-6.1%
[Analyst] Revisions Ratio: +0% (up=12, down=12)